by Communication Team | Aug 6, 2020 | ODYSSEY
Results from a sub-study of the ODYSSEY trial, published in The Lancet HIV journal, show that children over 20kg in weight can safely take adult doses (50mg) of the anti-HIV drug dolutegravir. With over half of children living with HIV globally weighing at over 20kg,...
by Communication Team | Aug 6, 2020 | Publication
Authors: Bollen PDJ, Moore C, Mujuru H, et al. The ODYSSEY Trial TeamPublished in: LANCET HIV. 2020;8:e533-e544 Download
Recent Comments